Live from the NIH registry
Studies recruiting near Brooklyn right now
Top 25 of 4,259 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Laura and Isaac Perlmutter Cancer Center at NYU Langone — New York, New York (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
Harlem Prevention Center — New York, New York (5.3 mi)
· Sponsor: Westat
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
Cancer, Period Problem
Phase 2
Interventional 60 participants sought
Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York (5.3 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
NYC Research Inc — Long Island City, New York (6.5 mi)
· Sponsor: Medtronic MiniMed, Inc.
Mobile CBT for Middle Aged and Older Adults
Anxiety Disorders and Symptoms, Depressive Symptoms
N/A
Interventional 60 participants sought
Weill Cornell Medicine — New York, New York (5.3 mi)
· Sponsor: Weill Medical College of Cornell University
E-cigarettes for Harm Reduction Among Smokers With Serious Mental Illness
Cigarette Smoking
N/A
Interventional 60 participants sought
NYU Langone Health — New York, New York (5.3 mi)
· Sponsor: NYU Langone Health
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
Montefiore Einstein Medical Center — The Bronx, New York (14.5 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
Effects of Hip Bump Manipulation Versus Sham Treatment in Healthy Adults
Assessment of Hip Strength, Range of Motion, EMG Activation, and Landing Mechanics in Healthy Subjects, Healthy Adult Subjects
N/A
Interventional 60 participants sought
Dominican University New York — Orangeburg, New York (27.4 mi)
· Sponsor: Dominican University New York
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Multiple Myeloma
Phase 3
Interventional 944 participants sought
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street). — New York, New York (5.3 mi)
· Sponsor: Pfizer
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
Colorectal Cancer
N/A
Interventional 880 participants sought
Columbia University Irving Medical Center — New York, New York (5.3 mi)
· Sponsor: Columbia University
Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)
Stroke, Cerebrovascular Accident
N/A
Interventional 150 participants sought
Hackensack Meridian Health - JFK Johnson Rehabilitation Institute — Edison, New Jersey (25.9 mi)
· Sponsor: Hackensack Meridian Health
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
Plasma Cell Myeloma Refractory
Phase 1
Interventional 87 participants sought
Hackensack Meridian Health - Hackensack University Medical Center- Site Number : 8400001 — Hackensack, New Jersey (17.0 mi)
· Sponsor: Sanofi
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey (28.7 mi)
· Sponsor: Regeneron Pharmaceuticals
HLA Demographics Study in Adults With Type 1 Diabetes
Diabetes Mellitus, Type I
N/A
Observational 200 participants sought
Icahn School of Medicine at Mount Sinai — New York, New York (5.3 mi)
· Sponsor: GentiBio, Inc
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Metastatic Solid Tumors
Phase 1
Interventional 600 participants sought
Memorial Sloan Kettering Cancer Center — New York, New York (5.3 mi)
· Sponsor: Erasca, Inc.
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — New York, New York (5.3 mi)
· Sponsor: AstraZeneca
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Mount Sinai Chelsea — New York, New York (5.3 mi)
· Sponsor: SWOG Cancer Research Network
Bridge-Enhanced ACL Repair (BEAR) in Meniscus Repair
Meniscus Tear
N/A
Interventional 80 participants sought
NYU Langone Health — New York, New York (5.3 mi)
· Sponsor: NYU Langone Health
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Modern Migraine, MD — New York, New York (5.3 mi)
· Sponsor: AbbVie
Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors
Smoking Cessation
N/A
Interventional 50 participants sought
Institute for Nicotine & Tobacco Studies — New Brunswick, New Jersey (28.7 mi)
· Sponsor: Rutgers, The State University of New Jersey
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
Columbia University Cystic Fibrosis Program — New York, New York (5.3 mi)
· Sponsor: Jaeb Center for Health Research
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health — New York, New York (5.3 mi)
· Sponsor: Relay Therapeutics, Inc.
Evaluating SleepWhale Drops for Rest & Resilience
Sleep
N/A
Interventional 100 participants sought
Efforia — New York, New York (5.3 mi)
· Sponsor: Efforia, Inc
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
Hematologic Malignancies
Phase 2
Interventional 40 participants sought
Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York (5.3 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
Heavy Menstrual Bleeding
N/A
Interventional 7 participants sought
Rubino OB/GYN (Axia Women's Health) — West Orange, New Jersey (18.3 mi)
· Sponsor: Rejoni Inc.